Rifaximin short-term useful for irritable bowel syndrome: Long-term added value is unclear.
- Published in:
- Geneesmiddelenbulletin, 2024, v. 58, n. 9, p. 17
- By:
- Publication type:
- Article
Works matching IS 03044629 AND DT 2024 AND VI 58 AND IP 9
Results: 1
1